iBio, Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -5.8% | +38.9% | 0.0% | +48.8% | +33.1% | -4.2% | -30.6% | +92.4% | +313.0% | -30.2% | +19.6% | -29.0% | +207.9% | +56.0% | -32.4% | -58.5% | -30.3% | -19.3% | +327.5% | |
| – | -4.5% | +653.0% | -19.0% | +319.3% | +60.5% | -3.8% | -41.0% | +158.7% | +136.2% | -64.1% | +90.0% | -70.5% | +1,184.3% | +69.4% | -56.9% | -41.7% | -40.3% | -38.0% | +848.7% | |
| – | +0.9% | +5,368.3% | -12.4% | +212.5% | +97.8% | -21.5% | -18.7% | +164.5% | +142.4% | -64.9% | +97.0% | -72.3% | +1,146.6% | +40.4% | -70.7% | -67.7% | +94.0% | -39.6% | +557.1% | |
| – | +0.9% | +5,368.3% | -12.4% | +212.5% | +97.8% | -21.5% | -18.7% | +164.5% | +142.4% | -64.9% | +97.0% | -72.3% | +1,146.6% | +76.0% | -65.4% | -78.1% | +94.0% | -39.6% | +925.9% | |
| – | -27.7% | +99.0% | -77.4% | +1,338.5% | -13.4% | +70.3% | -79.6% | +117.1% | +36.2% | -71.1% | -57.1% | +29.3% | +5,697.9% | -1.7% | +10.4% | -96.7% | +249.5% | -85.3% | +951.4% | |
| – | – | – | – | – | -10.4% | +72.8% | -90.7% | +50.0% | -86.7% | +18.2% | -100.0% | – | +79,799,900.0% | -96.6% | +14,344.4% | +440.8% | – | – | – | |
| – | – | – | -26.7% | -18.2% | -72.3% | +140.3% | +0.0% | +116.7% | +196,623.1% | +0.1% | -1.7% | -3.1% | -85.0% | +849.9% | +20.2% | -81.9% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1.3% | +8.4% | +6.7% | -22.3% | -5.5% | -5.2% | -5.1% | -8.3% | -11.4% | -12.9% | -11.1% | -15.2% | -16.7% | -16.8% | +409.6% | +11.1% | -0.4% | +27.6% | -73.3% | |
| – | +20.4% | -94.4% | +610.9% | +85.2% | -49.6% | +19.2% | -90.8% | +219.7% | +2,081.8% | -1.7% | -0.6% | +4.5% | +33.6% | +2.2% | -6.5% | -28.1% | -71.3% | +12.1% | +61.3% | |
| – | +35.7% | -71.9% | +610.9% | +85.2% | -49.6% | +19.2% | -90.8% | +219.7% | +81.4% | -12.1% | +1.1% | +69.9% | +51.4% | +26.9% | +358.0% | -29.1% | -82.2% | +59.0% | +92.4% | |
| – | – | – | – | – | – | – | – | – | – | +7.6% | +7.7% | +8.1% | +163.8% | +72.1% | +2,201.1% | -38.9% | -93.0% | +37.4% | -58.3% | |
| – | +43.1% | -77.8% | +1,686.8% | +44.3% | -1.7% | -15.6% | -89.2% | +267.2% | -28.8% | -51.0% | +138.0% | +26.7% | +75.7% | +28.1% | +89.2% | -56.6% | -80.6% | +511.2% | +102.1% | |
| – | – | – | – | – | – | – | – | – | – | -0.7% | -0.8% | – | – | – | – | – | – | – | – | |
| – | – | – | -75.5% | -81.7% | +3,037.2% | -17.8% | +20.3% | +84.1% | -11.5% | -10.3% | +81.4% | -84.8% | +2,198.7% | +91.8% | -41.5% | -75.8% | +38.6% | -30.2% | +476.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | -97.8% | +34.7% | +13.4% | +27.6% | +25.0% | +27.5% | +13.5% | +13.3% | +10.1% | +19.3% | +78.0% | +231.8% | +211.5% | -95.5% | +3,410.2% | +525.7% | +174.1% | +891.1% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.